CTT Pharmaceutical Holdings, Inc.
CTTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001035422
In the last 90 days, CTT Pharmaceutical Holdings, Inc. insiders filed 11 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by CTT Pharmaceutical Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 11 filings
- 1 insider, $3.79K in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$3.79K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for CTT Pharmaceutical Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| CTT Pharmaceutical Holdings, Inc. | CEO | 1,056,800 | Sep 22, 2026 | 16 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 8, 2024 (view filing)2:04 PM ET | May 7 | 1 day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseShares Acquired | +9.50K | $0.04 | +$380 | +0.2%4.17M after | |
| May 8, 2024 (view filing)2:01 PM ET | May 2 | 6 daysLate | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseShares Acquired | +4.39K | $0.031 | +$136.03 | +0.1%4.16M after | |
| Oct 31, 2023 (view filing)4:33 PM ET | Feb 18, 2022 | 620 daysLate | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseAcquired | +500.0K | $0.02 | +$10.0K | +26.5%2.38M after | |
| Oct 31, 2023 (view filing)4:26 PM ET | Aug 18, 2022 | 439 daysLate | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseAcquired | +500.0K | $0.02 | +$10.0K | +36.1%1.88M after | |
| Mar 27, 2023 (view filing)3:49 PM ET | Mar 27 | Same day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseShares Acquired | +8.70K | $0.022 | +$191.4 | +1.0%883.5K after | |
| Mar 3, 2023 (view filing)11:36 AM ET | Mar 3 | Same day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseShares Acquired | +3.84K | $0.035 | +$134.4 | +0.4%874.8K after | |
| Feb 8, 2023 (view filing)10:47 AM ET | Feb 8 | Same day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseShares Acquired | +4.96K | $0.035 | +$173.6 | +0.6%871.0K after | |
| Jan 30, 2023 (view filing)10:23 AM ET | Jan 30 | Same day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseShares Acquired | +9.00K | $0.025 | +$225 | +1.1%866.0K after | |
| Jan 25, 2023 (view filing)4:28 PM ET | Jan 25 | Same day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseShares Acquired | +61.7K | $0.024 | +$1.48K | +7.8%857.0K after |